title: Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature.
abstract: The aim of this study was to review the literature on quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis, and to identify the specific aspects of quality of life that were studied and reported in this population. We also set out to report predictors of quality of life. Published research reports were included if they described quality of life in this population and met methodological quality according to a list of predefined criteria. Eight studies (7 in NF1, 1 in NF2, 0 in schwannomatosis), conducted between 2001 and 2013, met inclusion criteria. The methodological quality of the eight studies was mostly high according to ratings by predefined criteria. Most studies reported that patients with NF experience decreased quality of life when compared to the general population. Visibility and disease severity were strong predictors of skin-specific quality of life in NF1 patients. However, the majority of findings regarding predictors of quality of life were weak or inconclusive. Given the decreased quality of life in NF patients, it is important to examine more comprehensively the psychosocial factors in this population, especially in patients with NF2 and schwannomatosis. Mind body interventions that address these domains may provide comprehensive and efficacious long term treatment.
authors.affiliation: Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. avranceanu@partners.org
authors.forename: Ana-Maria
authors.initials: AM
authors.lastname: Vranceanu
authors.forename: Vanessa L
authors.initials: VL
authors.lastname: Merker
authors.forename: Elyse
authors.initials: E
authors.lastname: Park
authors.forename: Scott R
authors.initials: SR
authors.lastname: Plotkin
mesh_terms: D000328:Adult; D006801:Humans; D009442:Neurilemmoma / Q000628:therapy*; D017253:Neurofibromatoses / Q000628:therapy*; D009456:Neurofibromatosis 1 / Q000628:therapy*; D016518:Neurofibromatosis 2 / Q000628:therapy*; D011788:Quality of Life; D012196:Review Literature as Topic; D012878:Skin Neoplasms / Q000628:therapy*